Prevalence of self-medication in brazil and associated factors

Show simple item record

dc.contributor.author Dourado Arrais, Paulo Sergio
dc.contributor.author Porto Fernandes, Maria Eneida
dc.contributor.author Dal Pizzol, Tatiane da Silva
dc.contributor.author Ramos, Luiz Roberto [UNIFESP]
dc.contributor.author Mengue, Sotero Serrate
dc.contributor.author Luiza, Vera Lucia
dc.contributor.author Leao Tavares, Noemia Urruth
dc.contributor.author Farias, Mareni Rocha
dc.contributor.author Oliveira, Maria Auxiliadora
dc.contributor.author Bertoldi, Andrea Damaso
dc.date.accessioned 2019-01-21T10:29:35Z
dc.date.available 2019-01-21T10:29:35Z
dc.date.issued 2016
dc.identifier http://dx.doi.org/10.1590/s1518-8787.2016050006117
dc.identifier.citation Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 13s, 2016.
dc.identifier.issn 0034-8910
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/49280
dc.description.abstract OBJECTIVE: To analyze the prevalence and associated factors regarding the use of medicines by self-medication in Brazil. METHODS: This cross-sectional population-based study was conducted using data from the PNAUM (National Survey on Access, Use and Promotion of Rational Use of Medicines), collected between September 2013 and February 2014 by interviews at the homes of the respondents. All people who reported using any medicines not prescribed by a doctor or dentist were classified as self-medication practitioners. Crude and adjusted prevalence ratios (Poisson regression) and their respective 95% confidence intervals were calculated in order to investigate the factors associated with the use of self-medication by medicines. The independent variables were: sociodemographic characteristics, health conditions and access to and use of health services. In addition, the most commonly consumed medicines by self-medication were individually identified. RESULTS: The self-medication prevalence in Brazil was 16.1% (95% CI 15.0-17.5), with it being highest in the Northeast region (23.8% en
dc.description.abstract 95% CI 21.6-26.2). Following the adjusted analysis, self-medication was observed to be associated with females, inhabitants from the North, Northeast and Midwest regions and individuals that have had one, or two or more chronic diseases. Analgesics and muscle relaxants were the therapeutic groups most used for self-medication, with dipyrone being the most consumed medicines. In general, most of the medicines used for self-medication were classified as non-prescriptive (65.5%). CONCLUSIONS: Self-medication is common practice in Brazil and mainly involves the use of non-prescription medicines en
dc.description.abstract therefore, the users of such should be made aware of the possible risks. en
dc.description.sponsorship Departments of Science and Technology (DECIT) from the Secretariat of Science, Technology and Strategic Inputs (SCTIE) of the Ministry of Health [25000.111834/2]
dc.description.sponsorship Department for Pharmaceutical Services and Strategic Health Supplies (DAF) from the Secretariat of Science, Technology and Strategic Inputs (SCTIE) of the Ministry of Health [25000.111834/2]
dc.format.extent 13s
dc.language.iso eng
dc.publisher Iop Publishing Ltd
dc.relation.ispartof Revista De Saude Publica
dc.rights Acesso aberto
dc.subject Adults en
dc.title Prevalence of self-medication in brazil and associated factors en
dc.title Prevalência da automedicação no Brasil e fatores associados pt
dc.type Artigo
dc.description.affiliation Departamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, Brasil
dc.description.affiliation Departamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliation Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.affiliation Departamento de Medicina Social. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliation Departamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
dc.description.affiliation Departamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil
dc.description.affiliation Departamento de Ciências Farmacêuticas. Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, Brasil
dc.description.affiliation Departamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, Brasil
dc.description.affiliationUnifesp Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.sponsorshipID SCTIE: 25000.111834/2
dc.identifier.file S0034-89102016000300311.pdf
dc.identifier.scielo S0034-89102016000300311
dc.identifier.doi 10.1590/S1518-8787.2016050006117
dc.description.source Web of Science
dc.identifier.wos WOS:000391447400002



File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account